David D. Allison - 06 Jan 2022 Form 3 Insider Report for CinCor Pharma, Inc.

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
06 Jan 2022
Net transactions value
$0
Form type
3
Filing time
06 Jan 2022, 19:51:15 UTC
Previous filing
13 Jul 2021
Next filing
20 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CINC Stock Option (Right to Buy) 06 Jan 2022 Common Stock 29,411 $13.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal annual installments over a three-year period measured from one year following December 10, 2021, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney